No cure available for exposure to potentially deadly ionizing radiation
- UVA researchers have identified compounds that could lead to the first antidote for potentially deadly radiation exposure
- Research was spurred by government concern about terror attacks and nuclear accidents
- For people exposed to sufficient ionizing radiation, doctors can only try to ease their suffering until death
- 2016 is the 30th anniversary of the Chernobyl nuclear accident and the fifth anniversary of the Fukushima nuclear accident
University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.
Some of the compounds, including the drug rapamycin, have previously been shown to extend life in organisms such as worms and flies, though it’s unknown if they would have the same benefit in humans. UVA’s research suggests that these compounds, or similar drugs, might counter the deadly effects of ionizing radiation.
Currently there is no treatment for people exposed to lethal doses of radiation; doctors can only try to ease their suffering until death. “If you’re exposed to a very, very high dose, it’s rapid deterioration and immediate death,” explained John S. Lazo, PhD, of UVA’s Department of Pharmacology. “It’s the lower doses that people – particularly governments – are concerned about. The type of exposure that might result from a dirty bomb or a nuclear accident. How do we alleviate the effects? What’s the antidote? Right now, we just don’t have anything.”
Lazo and his colleague Elizabeth R. Sharlow, PhD, screened a library of more than 3,400 existing drugs, vitamins and other compounds to identify ones that might help cells withstand the effects of radiation exposure. The goal was to keep stem cells – the cells that produce the various cell types in the body – alive long enough to repair the damage caused by radiation.
“We wanted to find already approved drugs that would potentially keep stem cells, or progenitor cells, alive after radiation exposure,” Sharlow said. “That’s very much of interest to the NIH [National Institutes of Health] right now: How can we keep those self-renewing populations alive so they can actually help heal the effects of radiation exposure?”
After they identified potential leads, Sharlow created 3D computer models to compare the substances’ chemical structures. That analysis identified a cluster of promising compounds with similar structures – a tantalizing lead in the quest for an antidote. “If you’re a drug hunter, the way we are, this is really cool information,” Lazo said. “Because you can say, ‘Now I will look in the universe of 40 million compounds. What else looks like that? Are they useful?'”
He noted that it is unlikely any one drug or compound will work on its own. “A lot of us in this field think it will be a cocktail of things you take,” he said. “And if you think you need cocktails, you need the individual ingredients. That’s why we think this is pretty important – because it’s providing new ingredients for that cocktail.”
The Latest on: Radiation antidote
via Google News
The Latest on: Radiation antidote
- Novel nanotech antioxidant cocktail prevents medical diagnostic procedures ionizing radiation effectson March 5, 2021 at 3:02 am
Ionizing radiation (IR) exposure results in oxidative damage causing cytotoxic and genotoxic effects. Double-strand breaks (DSBs) are considered the most significant DNA lesions induced by ionizing ...
- Nuclear medicineon March 4, 2021 at 11:11 am
His face was paralyzed, and for a few weeks the doctor who had spent months counseling residents displaced by a massive nuclear disaster was himself a patient. The paralysis was temporary. But the ...
- Radiation Detection, Monitoring, & Safety Market Worth $2.3 Billion - Growing Prevalence of Cancer Worldwideon March 2, 2021 at 2:42 pm
The global radiation detection Market is poised to reach $2.26 Billion by 2022. Radiation safety market report provides crucial industry insights that will help your business grow ...
- Turn Challenges into Opportunities, says Debbie Gilley, an IAEA Radiation Protection Specialiston March 2, 2021 at 10:49 am
Debbie Gilley, IAEA Radiation Protection Specialist, speaking to state regulators at the Conference of Radiation Control Program Directors Annual Meeting about the radiotherapy training program she ...
- American College of Radiation Oncology names presidenton February 24, 2021 at 3:06 pm
Joanne Dragun, MD, is the American College of Radiation Oncology's new president, the group said Feb. 23. Dr. Dragun is the medical director of GenesisCare in Jacksonville, Fla. She has been an ACRO ...
- Baylor College of Medicine names new endowed chairson February 24, 2021 at 9:49 am
The Baylor College of Medicine Board of Trustees recently appointed eight faculty members to endowed chairs – Dr. Xiang Zhang, Dr. E. Ramsay Camp, ...
- Jacksonville, Florida GenesisCare Medical Director Installed as President of American College of Radiation Oncologyon February 23, 2021 at 9:59 am
Dr. Joanne Dragun, medical director of radiation oncology at GenesisCare in Jacksonville, Florida, will be installed as president of the American College of Radiation Oncology at the college's annual ...
- Seeing the invisible: Norris Cotton Cancer Center pioneers radiation vision camerason February 22, 2021 at 4:00 pm
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center said it is the first cancer center in the world to regularly use a camera system that captures images and real-time video during ...
- IAEA Launches Training Material to Strengthen Safety Culture in Medicineon February 22, 2021 at 10:14 am
Trait Talks Handbook, a study manual that offers practical recommendations for medical professionals to strengthen patterns of good behaviour and attitudes that contribute to a safe environment.
- Ashvattha Therapeutics to Present at 2021 AACR Virtual Special Conference on Radiation Science and Medicineon February 22, 2021 at 10:00 am
The first AACR Virtual Special Conference on Radiation Science and Medicine, in association with the AACR Radiation Science and Medicine Working Group, will be an interdisciplinary review of the ...
via Bing News